MedTrace Logo

Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

NCT02833012 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-04-11

No results posted yet for this study

Summary

To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and estimate of acetoacetate) levels after single dose administration of caprylic triglyceride (CT) oil, AC-1202, AC-1204, and Axona®.

Conditions

  • Healthy

Interventions

DRUG

Caprylic Triglyceride Oil

10 g Caprylic Triglyceride Oil (10.5 mL) at Hour 0 on Day 1

DRUG

AC-1202

60 g AC-1202 (shaken in 180 mL of water) at Hour 0 on Day 1

DRUG

Axona

40 g Axona (shaken in 120 mL of water) at Hour 0 on Day 1

DRUG

AC-1204

40 g AC-1204 (shaken in 120 mL of water) at Hour 0 on Day 1

Sponsors & Collaborators

  • Celerion

    collaborator INDUSTRY

  • Cerecin

    lead INDUSTRY

Principal Investigators

  • Colleen Hunsaker, D.O. · Celerion

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-09-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833012 on ClinicalTrials.gov